Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -544 | -328 | -231 | 4,464 | 4,615 |
| Other Working Capital | -201 | 79 | 38 | 687 | 441 |
| Other Operating Activity | 0 | 0 | 0 | -5,804 | -5,553 |
| Operating Cash Flow | $-745 | $-249 | $-193 | $-653 | $-497 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 284,916 | 284,916 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $284,916 | $284,916 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 493 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 258 | 258 | 229 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -284,916 | -284,916 |
| Other Financing Activity | 0 | 0 | 0 | 156 | 0 |
| Financing Cash Flow | $750 | $258 | $229 | $-284,760 | $-284,916 |
| Beginning Cash Position | 11 | 11 | 11 | 497 | 497 |
| End Cash Position | 17 | 20 | 47 | N/A | 0 |
| Net Cash Flow | $5 | $8 | $36 | $-497 | $-497 |
| Free Cash Flow | |||||
| Operating Cash Flow | -745 | -249 | -193 | -653 | -497 |
| Free Cash Flow | -745 | -249 | -193 | -653 | -497 |